Gowlings Logo Life Sciences News @ Gowlings
September 2, 2010
Life Sciences News @ Gowlings image
  Use Twitter?    Follow Gowlings news on Twitter

Pfizer to buy FoldRx Pharma
http://www.pharmatimes.com/Article/10-09-02/Pfizer_to_buy_FoldRx_Pharma.aspx

SunOpta sells its bioprocess business to Mascoma
http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=b4374990

Finding Suggests New Aim for Alzheimer’s Drugs
http://www.nytimes.com/2010/09/02/health/research/02alzheimer.html?_r=1&ref=science

Genetically altered fish on the table in the U.S.
http://www.vancouversun.com/news/Genetically+altered+fish+table/3473239/story.html

AIDS Cure Quest to Kill `Sleeping' Viruses Enlists Merck Cancer Medicine
http://www.bloomberg.com/news/2010-09-02/aids-cure-quest-to-kill-sleeping-viruses-enlists-merck-cancer-medicine.html

Merck/Cardiome heart drug OK in Europe
http://www.pharmatimes.com/Article/10-09-02/Merck_Cardiome_heart_drug_OK_in_Europe.aspx

Merck & Co postpones Dutch closures, options open
http://www.reuters.com/article/idUSLDE6810AB20100902

Orexigen, Takeda in marketing deal worth $1 bln for obesity drug
http://www.reuters.com/article/idUSSGE68117G20100902

Gimme five: Paralympian slaps 9,300 hands in world record attempt
http://www.cbc.ca/cp/Oddities/VG2909.html

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.
© 2010 Gowling Lafleur Henderson LLP. All rights reserved.